Growth investments Reach Separations has recently expanded UK and France laboratories with new Prep SFC systems, Prep HPLCs, and analytical instruments, signaling increased capacity and interest from clients in scale-up and rapid turnaround services. This presents a sales opportunity to offer scalable chromatography solutions, maintenance contracts, and related consumables.

Chiral expertise As specialists in chiral separation for small molecules, Reach Separations can be a preferred partner for pharmaceutical and agrochemical clients needing enantioselective analytics and purification, suggesting cross-selling of advanced chiral methods, method development, and training services.

Strategic partnerships Recent collaborations with CatSci and SFE Process indicate a proactive stance toward ecosystem partnerships. This opens avenues to propose joint development projects, preferred supplier arrangements, and bundled service offerings to their partner networks.

Mid-market focus With 11-50 employees and a revenue range of 1–10 million, Reach Separations sits in the mid-market for pharma services. Target opportunities include contracted analytical screening, discovery support services, and volume-based pricing for recurring projects from mid-sized biotech and specialty chemical firms.

Tech-enabled readiness Utilizing modern tools and platforms (Fastly, WordPress, Shopify, Google Tag Manager, etc.) alongside advanced HPLC and SFC technology signals a readiness to engage digital channels and offer remote monitoring, tech-enabled reporting, and streamlined customer onboarding for new clients.